A sleepy cannabis constituent: cannabinol and its active metabolite influence sleep architecture in rats
Abstract Medicinal cannabis is being used worldwide and there is increasing use of novel cannabis products in the community. Cannabis…
Iain S. McGregor
The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial
Abstract Current treatments for alcohol use disorders (AUD) have limited efficacy. Recently, Cannabidiol (CBD) has been examined in a multitude…
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)
Abstract Background: Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been…
The Effect of Cannabidiol on Subjective Responses to Endurance Exercise: A Randomised Controlled Trial
Abstract Background: Exercise is known to improve health. However, it can be unpleasant, often inducing negative feelings, or ‘affect’. Cannabidiol…
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Abstract Hand osteoarthritis (OA) is an irreversible degenerative condition causing chronic pain and impaired functionality. Existing treatment options are often…
Evaluating possible ‘next day’ impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s00213-024-06595-9. Article type: Research Article Keywords: cannabinoids, cognition, driving…
Detection of Δ9‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol containing oil
Abstract Point‐of‐collection testing (POCT) devices are widely used in roadside and workplace drug testing to identify recent cannabis use by…
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study
Abstract Introduction: Prescribed medicinal cannabis (MC) is an increasingly common prescription in Australia for treating pain, anxiety, and sleep disorders.…
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s42238-023-00202-y. Article type: Research Article Keywords: Medical cannabis, THC,…
Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review
Abstract Background: The current review broadly summarises the evidence base for pharmacotherapies and adjunctive and alternative therapies in the treatment…